Response to: "Risks of hydroxychloroquine use for COVID-19 prophylaxis".
作者信息
Grant-Kels Jane M
机构信息
Dermatology Department, University of Connecticut, Farmington, Connecticut; Dermatology Department, University of Florida, Gainesville, Florida.
出版信息
J Am Acad Dermatol. 2020 Jul;83(1):e75-e76. doi: 10.1016/j.jaad.2020.04.112. Epub 2020 Apr 26.
Abstract
摘要
相似文献
1
Response to: "Risks of hydroxychloroquine use for COVID-19 prophylaxis".回应：“使用羟氯喹预防新冠病毒病的风险”
J Am Acad Dermatol. 2020 Jul;83(1):e75-e76. doi: 10.1016/j.jaad.2020.04.112. Epub 2020 Apr 26.
2
The Risks of Prescribing Hydroxychloroquine in COVID-19-Infected Patients With Schizophrenia.在感染新冠病毒的精神分裂症患者中开具羟氯喹处方的风险
Prim Care Companion CNS Disord. 2020 Apr 30;22(3):20com02635. doi: 10.4088/PCC.20com02635.
3
Comment on: COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.关于《2019冠状病毒病：关于研究羟氯喹预防感染及病情进展效果的建议》的评论
J Antimicrob Chemother. 2020 Jul 1;75(7):2016-2017. doi: 10.1093/jac/dkaa169.
4
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
5
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物：证据说了什么？
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
6
Does hydroxychloroquine prevent the transmission of COVID-19?羟氯喹能预防新型冠状病毒肺炎的传播吗？
Ann Rheum Dis. 2020 Jun;79(6):e60. doi: 10.1136/annrheumdis-2020-217501. Epub 2020 Apr 15.
7
Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.羟氯喹预处理预防新型冠状病毒肺炎感染失败？一例病例报告。
J Antimicrob Chemother. 2020 Sep 1;75(9):2706-2707. doi: 10.1093/jac/dkaa213.
8
Lack of efficacy of hydroxychloroquine in covid-19.羟氯喹在新冠病毒肺炎中的疗效欠佳。
BMJ. 2020 May 19;369:m2018. doi: 10.1136/bmj.m2018.
9
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.羟氯喹能保护风湿病患者免受新型冠状病毒肺炎（COVID-19）感染吗？对Heldwein和Calado所著的《羟氯喹能预防新型冠状病毒肺炎（COVID-19）传播吗？》以及Joob和Wiwanitkit所著的《系统性红斑狼疮、羟氯喹与非系统性红斑狼疮的新型冠状病毒肺炎（COVID-19）患者：一则评论》的回应
Ann Rheum Dis. 2020 Jun;79(6):e62. doi: 10.1136/annrheumdis-2020-217524. Epub 2020 Apr 23.
10
Taking the Longer View of COVID-19.从更长远的视角看待新冠疫情。
Oncologist. 2020 Jun;25(6):455-457. doi: 10.1634/theoncologist.2020-0313. Epub 2020 Apr 27.
本文引用的文献
1
Risks of hydroxychloroquine use for COVID-19 prophylaxis.使用羟氯喹预防新冠病毒病的风险。
J Am Acad Dermatol. 2020 Jul;83(1):e73-e74. doi: 10.1016/j.jaad.2020.04.111. Epub 2020 Apr 26.
2
Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.羟氯喹在COVID-19危重症患者管理中的应用：循证依据的必要性。
Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15.
3
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.羟氯喹和阿奇霉素联合治疗至少随访 6 天的 80 例 COVID-19 患者的临床和微生物学效果：一项前瞻性观察研究。
Travel Med Infect Dis. 2020 Mar-Apr;34:101663. doi: 10.1016/j.tmaid.2020.101663. Epub 2020 Apr 11.
4
Does hydroxychloroquine combat COVID-19? A timeline of evidence.羟氯喹能对抗新冠病毒吗？证据时间表。
J Am Acad Dermatol. 2020 Jul;83(1):e33-e34. doi: 10.1016/j.jaad.2020.04.031. Epub 2020 Apr 10.
5
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
6
Hydroxychloroquine in the treatment of rheumatoid arthritis.
Am J Med. 1983 Aug;75(2):321-6. doi: 10.1016/0002-9343(83)91211-1.
Zotero 插件